Segment Information - Summary of Financial Information for the Company's Segments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information
Consolidated revenue	$ 324,239	$ 252,483
Total segment depreciation expense	2,864	1,526
Total segment amortization	3,009	2,885
Goodwill impairment charges	16,867	9,944
Selling, general and administrative expense	113,851	119,689
Non-segment depreciation and amortization	5,873	4,411
Loss from operations	(77,018)	(81,951)
Operating segments
Segment Reporting Information
Consolidated revenue	324,239	252,483
Total segment direct costs	264,666	200,390
Total segment depreciation expense	2,263	1,207
Total segment amortization	3,009	2,886
Total segment operating income	54,301	48,000
Goodwill impairment charges	16,867	9,944
Selling, general and administrative expense	113,851	119,689
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	601	318
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	213,504	166,785
Total segment direct costs	181,017	134,761
Total segment depreciation expense	2,156	1,202
Total segment amortization	2,799	2,675
Total segment operating income	27,532	28,147
Goodwill impairment charges	16,235	9,944
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	103,835	79,343
Total segment direct costs	83,071	65,111
Total segment depreciation expense	106	4
Total segment operating income	20,658	14,228
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	6,900	6,355
Total segment direct costs	578	518
Total segment depreciation expense	1	1
Total segment amortization	210	211
Total segment operating income	6,111	5,625
Goodwill impairment charges	$ 632	$ 0